In the News

31/07/2017

‘If Canada was efficient, I wouldn't exist:’ The miraculous success of Jonathan Ross Goodman

21/10/2016

EY Entrepreneur Of The Year Awards Québec 2016

20/09/2016

Knight Therapeutics "to get real" as it builds its commercial operations

12/04/2016

Forbion Capital Fund closes at $208 mln

15/03/2016

Knight Therapeutics reacquires leishmaniasis drug Impavido

23/02/2016

Knight CFO named finalist in the 2016 Aces of Finance Competition

08/10/2015

The lights are dimming for specialty pharma

05/05/2015

Knight Therapeutics: A solid long-term bet in the health care space

18/12/2014

U.S. program may alter the economics of Ebola vaccines

19/11/2014

Knight Therapeutics sells fast-track drug certificate

19/11/2014

Gilead Buys Shortcut For FDA Drug Review For $125 Million

19/11/2014

How Much? Gilead Pays $125M For an FDA Priority Review Voucher

19/11/2014

Gilead Buys Shortcut For FDA Drug Review For $125 Million

23/10/2014

Looking to repeat the feat

23/10/2014

Looking to repeat the feat